Q1 Earnings Estimate for CME Group Issued By Zacks Research

Key Points

• Zacks Research has revised down its Q1 2027 EPS estimate for CME Group from $3.11 to $3.07, while maintaining a full-year earnings estimate of $10.49 per share.
• The company’s stock has received mixed ratings, with five analysts recommending a Buy rating, while three analysts suggest a Sell.
• CME Group recently announced a quarterly dividend of $1.25 per share, representing a yield of 1.9% and a payout ratio of 48.40%.

CME Group Inc. (NASDAQ:CME - Free Report) - Equities research analysts at Zacks Research cut their Q1 2027 EPS estimates for CME Group in a research report issued to clients and investors on Monday, September 29th. Zacks Research analyst Team now forecasts that the financial services provider will post earnings of $3.07 per share for the quarter, down from their prior estimate of $3.11. The consensus estimate for CME Group's current full-year earnings is $10.49 per share. Zacks Research also issued estimates for CME Group's FY2027 earnings at $12.29 EPS.

Several other equities research analysts have also recently weighed in on CME. Wall Street Zen cut shares of CME Group from a "hold" rating to a "sell" rating in a research report on Sunday, July 13th. JPMorgan Chase & Co. upped their price objective on shares of CME Group from $246.00 to $252.00 and gave the stock an "underweight" rating in a research report on Thursday, September 25th. Piper Sandler upped their price objective on shares of CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 15th. Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. Finally, Oppenheimer upped their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $268.71.

CME Group Trading Down 1.6%

CME opened at $265.84 on Thursday. CME Group has a twelve month low of $213.94 and a twelve month high of $290.79. The company has a 50-day simple moving average of $270.51 and a 200 day simple moving average of $271.09. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market capitalization of $95.80 billion, a price-to-earnings ratio of 25.73, a P/E/G ratio of 4.90 and a beta of 0.41.

CME Group (NASDAQ:CME - Get Free Report) last announced its earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.56 earnings per share.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a dividend of $1.25 per share. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.9%. CME Group's payout ratio is presently 48.40%.

Insiders Place Their Bets

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the company's stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares of the company's stock, valued at $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the company's stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the completion of the transaction, the insider directly owned 17,440 shares of the company's stock, valued at $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock worth $3,527,956 in the last ninety days. Insiders own 0.30% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. increased its stake in shares of CME Group by 1.5% in the second quarter. Vanguard Group Inc. now owns 35,176,376 shares of the financial services provider's stock valued at $9,695,313,000 after buying an additional 532,549 shares during the period. Geode Capital Management LLC increased its stake in shares of CME Group by 3.6% in the second quarter. Geode Capital Management LLC now owns 9,178,681 shares of the financial services provider's stock valued at $2,524,271,000 after buying an additional 319,899 shares during the period. Norges Bank acquired a new position in shares of CME Group in the second quarter valued at approximately $1,571,447,000. Ameriprise Financial Inc. increased its position in CME Group by 2.0% during the 2nd quarter. Ameriprise Financial Inc. now owns 4,682,066 shares of the financial services provider's stock valued at $1,289,910,000 after purchasing an additional 92,925 shares during the period. Finally, Raymond James Financial Inc. increased its position in CME Group by 9.7% during the 1st quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider's stock valued at $1,091,401,000 after purchasing an additional 363,130 shares during the period. Institutional investors and hedge funds own 87.75% of the company's stock.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.